Prevention and early detection of prostate cancer.

• Cuzick J Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK. Electronic address: j.cuzick@qmul.ac.uk.
• Thorat MA Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
• Andriole G Division of Urologic Surgery, Barnes-Jewish Hospital, Washington University School of Medicine, St Louis, MO, USA.
• Brawley OW Office of the Chief Medical Officer, American Cancer Society, Atlanta, GA, USA; Department of Hematology and Oncology, Emory University, Atlanta, GA, USA.
• Brown PH Department of Clinical Cancer Prevention, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• Culig Z Molecular Pathology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria.
• Eeles RA Division of Cancer Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
• Ford LG Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
• Hamdy FC Urology, University of Oxford, Oxford, UK.
• Holmberg L Medical School, King's College London, London, UK; Regional Cancer Center Uppsala Orebro and Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
• Ilic D School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
• Key TJ Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
• La Vecchia C Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
• Lilja H Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Surgery (Urology), Laboratory Medicine, and Medicine (GU-Oncology), Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Laboratory Medicine, Lund University, University Hospital UMAS, Malmö, Sweden.
• Marberger M Department of Urology, Vienna University Medical School, Vienna, Austria.
• Meyskens FL Biological Chemistry, Public Health, and Epidemiology, School of Medicine, University of California, Irvine, CA, USA.
• Minasian LM Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
• Parker C Academic Urology Unit, Royal Marsden NHS Foundation Trust, London, UK.
• Parnes HL Prostate and Urologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
• Perner S Department of Prostate Cancer Research, Institute of Pathology, University Hospital of Bonn, Bonn, Germany.
• Rittenhouse H Director of Assay Development, IR2Dx Inc Moraga, CA, USA.
• Schalken J Urology, Radboud University Medical Center, Nijmegen, Netherlands.
• Schmid HP Department of Urology, Kantonsspital St Gallen, St Gallen, Switzerland.
• Schmitz-Dräger BJ Urologie, Schön Klinik Nürnberg/Fürth & Urologie 24, Fürth, Germany.
• Schröder FH Erasmus University and Erasmus Medical Centre, Rotterdam, Netherlands.
• Stenzl A Department of Urology, University Hospital Tübingen, Tuebingen, Germany.
• Tombal B Department of Urology, Université Catholique de Louvain, Brussels, Belgium.
• Wilt TJ Center for Chronic Disease Outcomes Research, Minneapolis Veterans Affairs Health Care System, and Section of General Medicine, University of Minnesota School of Medicine, Minneapolis, MN, USA.
• Wolk A Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Show more…

Age Factors

Aged

Aged, 80 and over

Biomarkers, Tumor

Biopsy, Needle

Early Detection of Cancer

Evidence-Based Medicine

Humans

Immunohistochemistry

Life Style

Male

Middle Aged

Neoplasm Invasiveness

Primary Prevention

Prognosis

Prostate-Specific Antigen

Prostatic Neoplasms

Risk Factors

Risk Reduction Behavior